Active Stocks
Fri Jun 27 2025 15:59:58
  1. Tata Steel share price
  2. 161.40 0.56%
  1. Itc share price
  2. 418.95 -0.33%
  1. Tata Motors share price
  2. 686.70 0.54%
  1. Ntpc share price
  2. 337.95 0.24%
  1. State Bank Of India share price
  2. 805.40 1.05%
Business News/Market/Market Stats/    Alembic Pharmaceuticals

ALEMBIC PHARMACEUTICALS SUMMARY

Alembic Pharmaceuticals is trading 0.02% upper at Rs 974.20 as compared to its last closing price. Alembic Pharmaceuticals has been trading in the price range of 989.40 & 963.75. Alembic Pharmaceuticals has given -8.6% in this year & 4.45% in the last 5 days.

 

Alembic Pharmaceuticals has TTM P/E ratio 31.32 as compared to the sector P/E of 22.67. There are 11 analysts who have initiated coverage on Alembic Pharmaceuticals. There are 3 analysts who have given it a strong buy rating & 2 analysts have given it a buy rating. 0.00 analysts have given the stock a sell rating.

 

The company posted a net profit of 156.87 Crores in its last quarter.

 

Listed peers of Alembic Pharmaceuticals include Syngene International (-0.42%), Eris Lifesciences (3.75%), Alembic Pharmaceuticals (0.02%) etc.

 

Alembic Pharmaceuticals has a 69.67% promoter holding & 30.33% public holding.

FAQs about Alembic Pharmaceuticals

Alembic Pharmaceuticals is trading at 974.20 as on 27 Jun, 2025 3:29:57 PM. This is 0.02% upper as compared to its previous closing price of 974.05
The market capitalization of Alembic Pharmaceuticals is 19149.18 Cr as on 27 Jun, 2025 3:29:57 PM.
The average broker rating on Alembic Pharmaceuticals is Buy. The breakup of analyst rating is given below -
  • 1 analysts have given a strong sell rating
  • 0.00 analysts have given a sell rating
  • 5 analysts have given a hold rating
  • 2 analysts have given a buy rating
  • 3 analysts have given a strong buy rating
The 52 wk high for Alembic Pharmaceuticals is 1296.15 whereas the 52 wk low is 725.60
Alembic Pharmaceuticals can be analyzed on the following key metrics -
  • TTM P/E: 31.32
  • Sector P/E: 22.67
  • Dividend Yield: 1.13%
  • D/E ratio: -
Alembic Pharmaceuticals reported a net profit of 583.42 Cr in 2025.
Recommended For You